116 related articles for article (PubMed ID: 26253632)
1. Biarylmethoxy 2-nitroimidazooxazine antituberculosis agents: Effects of proximal ring substitution and linker reversal on metabolism and efficacy.
Thompson AM; Blaser A; Palmer BD; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
Bioorg Med Chem Lett; 2015 Sep; 25(18):3804-9. PubMed ID: 26253632
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074
[TBL] [Abstract][Full Text] [Related]
3. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.
Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT
Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
[TBL] [Abstract][Full Text] [Related]
5. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824).
Thompson AM; Sutherland HS; Palmer BD; Kmentova I; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
J Med Chem; 2011 Oct; 54(19):6563-85. PubMed ID: 21846109
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
8. Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
Ng PS; Manjunatha UH; Rao SP; Camacho LR; Ma NL; Herve M; Noble CG; Goh A; Peukert S; Diagana TT; Smith PW; Kondreddi RR
Eur J Med Chem; 2015 Dec; 106():144-56. PubMed ID: 26544629
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and biological evaluation of novel bicyclic nitroimidazole derivatives.
Zaprutko L; Zwawiak J; Augustynowicz-Kopeć E; Zwolska Z; Bartoszak-Adamska E; Nowicki W
Arch Pharm (Weinheim); 2012 Jun; 345(6):463-7. PubMed ID: 22266946
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Palmer BD; Thompson AM; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
J Med Chem; 2010 Jan; 53(1):282-94. PubMed ID: 19928920
[TBL] [Abstract][Full Text] [Related]
11. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.
Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS
Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS
J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889
[TBL] [Abstract][Full Text] [Related]
13. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).
Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE
J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Blaser A; Palmer BD; Sutherland HS; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Thompson AM; Denny WA
J Med Chem; 2012 Jan; 55(1):312-26. PubMed ID: 22148391
[TBL] [Abstract][Full Text] [Related]
16. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
[TBL] [Abstract][Full Text] [Related]
17. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
[TBL] [Abstract][Full Text] [Related]
18. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
Shalini ; Viljoen A; Kremer L; Kumar V
Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
[TBL] [Abstract][Full Text] [Related]
19. Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.
Keller PM; Hömke R; Ritter C; Valsesia G; Bloemberg GV; Böttger EC
Antimicrob Agents Chemother; 2015 Jul; 59(7):4352-5. PubMed ID: 25941226
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
